Abstract
This investigation sought to discover whether purification of monoclonal antibody CB.Hep-1 in ascitic fluid is possible by protein A–Sepharose affinity chromatography, for 100 runs, without pre-purification steps. Results showed that direct application of ascitic fluid to protein A–Sepharose increased monoclonal antibody recovery by 27% compared with the traditional process (control) after 100 runs. The purity of the monoclonal antibody was >95% and the cost of the purification was 15% less than that of the control process. In conclusion, monoclonal antibody CB.Hep-1 in ascitic fluid can be purified by chromatography on protein A–Sepharose, for 100 purification cycles, without the need for pre-purification steps.
Similar content being viewed by others
References
Köhler G, Milstein C (1975) Nature 256:485–497
Waldmann TA, Levy R, Coller BS (2000) Hematology 1:394–408
Haughton AN, Scheinberg DA (2000) Nat Med 6:373–374
Reichert JM (2003) Nat Rev Drug Discov 2:695–702
Reichert JM, Pavlou (2004) Nat Rev Drug Discov 3:383–384
Clark M (1997) Chem Immunol 65:88–110
Eliasson M, Andersson R, Olsson A, Wigzell H, Uhlen M (1989) J Immunol 142:575–581
Hardy E, Martínez E, Diago D, Díaz R, González D, Herrera L (2000) J Biotechnol 77:157–167
Premstaller A, Oberacher H, Walcher W, Timperio A-M, Zolla L, Chervet J-P, Cavusoglu N, Van Dorsellaer A, Huber CG (2001) Anal Chem 73:2390–2396
Mahn A, Asenjo JA (2005) Biotechnol Adv 23:359–368
Burtonan SC, Harding DRK (2001) J Biochem Biophys Methods 49:275–287
Hu W, Liu Z, Ji D, Xie H, Gong D, Li L (2006) J Nephrol 19:312–317
Blank GS, Zapata G, Fahrner R, Milton M, Yedinak C, Knudsen H, Schmelzer C (2001) Bioseparation 10:65–71
Valdés R, Gómez L, Padilla S, Brito J, Reyes B, Álvarez T, Mendoza O, Herrera O, Ferro W, Pujol M, Leal V, Linares M, Hevia Y, García C, Mila L, García O, Sánchez R, Acosta A, Geada D, Paez R, Luis Vega J, Borroto C (2003) Biochem Biophys Res Commun 308(1):94–100
Lowry OH, Rosenbrough NJ, Farr AL, Randal R (1951) J Biol Chem 193:265–275
Cossío MEF, Díaz T, Galván A, Valdés R, González E, Ayala M, Díaz J, Bestagno M, Burrone O, Gavilondo J (1997) J Biotechnol 56:69–80
Laemmli UK (1970) Nature 227:680–685
Valdés R, Ibarra N, Ruibal I, Beldarraín A, Noa E, Herrera N, Alemán R, Padilla S, Garcia J, Pérez M, Morales R, Chong E, Reyes B, Quiñones Y, Agraz A, Herrera L (2002) J Biotechnol 96:251–258
Schwartz W, Judd D, Wysocki M, Guerrier L, Birck-Wilson E, Boschetti E (2001) J Chromatogr B 908:251–263
Valdés R, Díaz T, Nieto A, García C, Pérez M, García J, Quiñones Y (1995) Biotecnol Apl 12(2):115–119
Acknowledgments
The authors would like to thank to the Monoclonal Antibody Department of the Center for Genetic Engineering and Biotechnology for their contribution to this comparison study. The authors also gratefully acknowledge Mena Cayetana Ramos from ‘Salvador Allende’ hospital for her effort to make possible the publication of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Valdés, R., Álvarez, T., Tamayo, A. et al. New Mab CB.Hep-1 Purification Process Eliminates the Need for Pre-Chromatographic Purification. Stability Demonstrated Over 100 Purification Cycles. Chroma 67, 923–927 (2008). https://doi.org/10.1365/s10337-008-0607-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-008-0607-5